| Histamine H3 receptor and cholinesterases as synergistic targets for cognitive decline: Strategies to the rational design of multitarget ligands FB Lopes, CMSQ Aranha, JPS Fernandes Chemical Biology & Drug Design 98 (2), 212-225, 2021 | 13 | 2021 |
| Evaluation of the histamine H3 receptor antagonists from LINS01 series as cholinesterases inhibitors: Enzymatic and modeling studies FB Lopes, CMSQ Aranha, MF Corrêa, GAB Fernandes, DN Okamoto, ... Chemical Biology & Drug Design 100 (5), 722-729, 2022 | 4 | 2022 |
| Multitargeting approaches to cognitive impairment: Synthesis of aryl-alkylpiperazines and assessment at cholinesterases, histamine H3 and dopamine D3 receptors CMSQ Aranha, D Reiner-Link, LR Leitzbach, FB Lopes, H Stark, ... Bioorganic & Medicinal Chemistry 78, 117132, 2023 | 2 | 2023 |
| Antihistamines H1 as Potential Anthelmintic Agents against the Zoonotic Parasite Angiostrongylus cantonensis DB Roquini, BL Lemes, ALB Kreutz, SC Spoladore, MC Amaro, FB Lopes, ... ACS omega 9 (28), 31159-31165, 2024 | | 2024 |
| Fragment-based design of anticholinesterase and chelating agents in a multi-target approach FB Lopes, JP dos Santos Fernandes Galoá, 2022 | | 2022 |
| Heterocyclic multitargeting ligands of cholinesterases, histamine and dopamine receptor subtypes: promising agents for cognitive dysfunctions C Aranha, D Reiner-Link, L Leitzbach, FB Lopes, D Okamoto, H Stark, ... Galoá, 2022 | | 2022 |
| Tackling Neuroinflammation in Cognitive Disorders with Single-Targeted and Multi-Targeted Histamine H3 Receptor Modulators FB Lopes, JPS Fernandes, E Uliassi Current topics in medicinal chemistry, 0 | | |
